8/29/2013

Only 3.2% of diabetic retinopathy patients who took nepafenac ophthalmic suspension 0.1% developed macular edema at 90 days following cataract surgery, compared with 16.7% of those who received vehicle treatment, a study revealed. Researchers also noted better visual acuity and fewer lost letters in the nepafenac arm than those in the vehicle group. The results were presented at the American Society of Retina Specialists meeting.

Related Summaries